UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Journal of clinical oncology, 2000-08, Vol.18 (16), p.2938-2947

2000

Volltextzugriff (PDF)

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients

Annals of oncology, 2005-07, Vol.16 (7), p.1081-1086

2005

Volltextzugriff (PDF)

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Annals of oncology, 2012-04, Vol.23 (4), p.1016-1022

2012

Volltextzugriff (PDF)

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Journal of clinical oncology, 2023-11, Vol.41 (33), p.5080-5089

2023

Volltextzugriff (PDF)

Influence of Endocrine-Related Factors on Response to Perioperative Chemotherapy for Patients With Node-Negative Breast Cancer

Journal of clinical oncology, 2001-11, Vol.19 (21), p.4141-4149

2001

Volltextzugriff (PDF)

Progress in the development and acquisition of anticancer agents from marine sources

Annals of oncology, 2003-11, Vol.14 (11), p.1607-1615

2003

Volltextzugriff (PDF)

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline taxane-based chemotherapy

British journal of cancer, 2006-11, Vol.95 (9), p.1161-1166

2006

Volltextzugriff (PDF)

Safety and efficacy of moderate-dose capecitabine as first-line therapy in metastatic breast cancer

Expert review of anticancer therapy, 2011-02, Vol.11 (2), p.165-168

2011

Volltextzugriff (PDF)

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients

Annals of oncology, 2011-03, Vol.22 (3), p.595-602

2011

Volltextzugriff (PDF)

First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours

British journal of cancer, 2012-04, Vol.106 (8), p.1379-1385

2012

Volltextzugriff (PDF)

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

The Lancet (British edition), 2000-05, Vol.355 (9218), p.1869-1874

2000

Volltextzugriff (PDF)

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5568-5577

2005

Volltextzugriff (PDF)

It is not time to stop progesterone receptor testing in breast cancer

Journal of clinical oncology, 2005-06, Vol.23 (16), p.3868-3869

2005

Volltextzugriff (PDF)

186 Mechanistic Differences Between a New Platinum(II) Monosulphonamide and Cisplatin in Melanoma Cell Lines

European journal of cancer (1990), 2012-11, Vol.48, p.56-56

2012

Volltextzugriff (PDF)

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2013-07, Vol.72 (1), p.75-83

2013

Volltextzugriff (PDF)

5116 POSTER Evidence of No Benefit for Extensive Axillary Dissection in Lymph Node-positive Early Breast Cancer Treated With Adjuvant Radiation

European journal of cancer (1990), 2011, Vol.47, p.S364-S365

2011

Volltextzugriff (PDF)

5113 POSTER Getting Deep in the Luminal B Breast Cancer Subtype and Its Ki67 Cutoff Value

European journal of cancer (1990), 2011, Vol.47, p.S363-S364

2011

Volltextzugriff (PDF)

Extensive experience of disease control with gefitinib and the role of prognostic markers

British journal of cancer, 2003-12, Vol.89 (S2), p.S3-S8

2003

Volltextzugriff (PDF)

Altretamine for recurrent ovarian cancer or as maintenance after response to second-line therapy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15589-e15589

2011

Volltextzugriff (PDF)

5111 POSTER Infiltrating Lobular Carcinoma of the Breast – a Hospital General Experience

European journal of cancer (1990), 2011, Vol.47, p.S363-S363

2011

Volltextzugriff (PDF)

1422 POSTER Observational Cohort Study of Plasma Levels of Biomarkers in Patients With Non-small Cell Lung Cancer Treated With Bevacizumab

European journal of cancer (1990), 2011, Vol.47, p.S176-S176

2011

Volltextzugriff (PDF)

Therapeutic management of chronic lymphocytic leukaemia State of the art and future perspectives

Critical reviews in oncology/hematology, 2011-10, Vol.80 (1), p.100-113

2011

Volltextzugriff (PDF)

Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study

European journal of cancer (1990), 1996-02, Vol.32 (2), p.243-248

1996

Volltextzugriff (PDF)

Guidelines for the management of breakthrough pain in patients with cancer

Journal of the National Comprehensive Cancer Network, 2013-03, Vol.11 Suppl 1 (suppl 1), p.S29-S-36

2013

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(297)
Mit Volltextzugriff
(279)

Publikationsform

Artikel
(309)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(162)
Science & Technology
(140)
Life Sciences & Biomedicine
(139)
Oncology
(128)
Female
(123)
Middle Aged
(103)
Biological And Medical Sciences
(101)
Medical Sciences
(101)
Adult
(90)
Aged
(82)
Male
(76)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(65)
Pharmacology. Drug Treatments
(62)
Chemotherapy
(60)
Antineoplastic Agents
(57)
Treatment Outcome
(46)
Breast Cancer
(40)
Breast Neoplasms - Drug Therapy
(40)
Tumors
(40)
Breast Neoplasms - Pathology
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Influence of Endocrine-Related Factors on Response to Perioperative Chemotherapy for Patients With Node-Negative Breast Cancer

Progress in the development and acquisition of anticancer agents from marine sources

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline taxane-based chemotherapy

Safety and efficacy of moderate-dose capecitabine as first-line therapy in metastatic breast cancer

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients

First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

It is not time to stop progesterone receptor testing in breast cancer

186 Mechanistic Differences Between a New Platinum(II) Monosulphonamide and Cisplatin in Melanoma Cell Lines

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors

5116 POSTER Evidence of No Benefit for Extensive Axillary Dissection in Lymph Node-positive Early Breast Cancer Treated With Adjuvant Radiation

5113 POSTER Getting Deep in the Luminal B Breast Cancer Subtype and Its Ki67 Cutoff Value

Extensive experience of disease control with gefitinib and the role of prognostic markers

Altretamine for recurrent ovarian cancer or as maintenance after response to second-line therapy

5111 POSTER Infiltrating Lobular Carcinoma of the Breast – a Hospital General Experience

1422 POSTER Observational Cohort Study of Plasma Levels of Biomarkers in Patients With Non-small Cell Lung Cancer Treated With Bevacizumab

Therapeutic management of chronic lymphocytic leukaemia State of the art and future perspectives

Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer

Guidelines for the management of breakthrough pain in patients with cancer

Suchergebnisse filtern